Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 339

1.

Therapeutic drug monitoring of quetiapine in adolescents with psychotic disorders.

Gerlach M, Hünnerkopf R, Rothenhöfer S, Libal G, Burger R, Clement HW, Fegert JM, Wewetzer Ch, Mehler-Wex C.

Pharmacopsychiatry. 2007 Mar;40(2):72-6.

PMID:
17447177
2.

Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: an open-label trial in adolescents with psychotic disorders.

McConville BJ, Arvanitis LA, Thyrum PT, Yeh C, Wilkinson LA, Chaney RO, Foster KD, Sorter MT, Friedman LM, Brown KL, Heubi JE.

J Clin Psychiatry. 2000 Apr;61(4):252-60.

PMID:
10830145
3.

Open-label study of the effect of combination quetiapine/lithium therapy on lithium pharmacokinetics and tolerability.

Potkin SG, Thyrum PT, Bera R, Carreon D, Alva G, Kalali AH, Yeh C.

Clin Ther. 2002 Nov;24(11):1809-23.

PMID:
12501876
4.

Quetiapine in adolescents with non-affective psychotic disorders: an open-label trial.

Holzer L, Preuss U, Baumgartner L, Jaugey L, Urben S, Halfon O, Baumann P.

Pharmacopsychiatry. 2011 May;44(3):87-95. doi: 10.1055/s-0031-1271682. Epub 2011 Feb 11.

PMID:
21318938
5.

The efficacy and safety of quetiapine for treatment of geriatric psychosis.

Yang CH, Tsai SJ, Hwang JP.

J Psychopharmacol. 2005 Nov;19(6):661-6.

PMID:
16272189
6.

Quetiapine in the treatment of psychotic adolescents: a case series of 23 patients with severe early onset psychosis.

Beer F, Heinrich H, Springer S, Rüth U, Freisleder FJ.

World J Biol Psychiatry. 2007;8(1):38-41.

PMID:
17366348
7.

Serum concentrations, therapeutic response and side effects in children and adolescents with impulsive-aggressive symptoms during risperidone therapy.

Klampfl K, Taurines R, Preuss A, Burger R, Rothenhöfer S, Wewetzer Ch, Pfuhlmann B, Fegert J, Gerlach M, Mehler-Wex C.

Pharmacopsychiatry. 2010 Mar;43(2):58-65. doi: 10.1055/s-0029-1239540. Epub 2009 Dec 10.

PMID:
20336598
8.

Effect of fluoxetine and imipramine on the pharmacokinetics and tolerability of the antipsychotic quetiapine.

Potkin SG, Thyrum PT, Alva G, Carreon D, Yeh C, Kalali A, Arvanitis LA; Pharmacokinetic Study Group.

J Clin Psychopharmacol. 2002 Apr;22(2):174-82.

PMID:
11910263
9.
10.

Quetiapine in combination with citalopram in patients with unipolar psychotic depression.

Konstantinidis A, Hrubos W, Nirnberger G, Windhager E, Lehofer M, Aschauer H, Kasper S.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jan 30;31(1):242-7. Epub 2006 Sep 7.

PMID:
16962224
11.

Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics.

Spina E, Avenoso A, Facciolà G, Scordo MG, Ancione M, Madia AG, Ventimiglia A, Perucca E.

Psychopharmacology (Berl). 2000 Jan;148(1):83-9.

PMID:
10663421
12.

[Generic quetiapine in the treatment of acute schizophrenia and schizoaffective disorder].

György B, Robert K, László C, Andrea J; Ketilept Vizsgáló Munkacsoport.

Neuropsychopharmacol Hung. 2008 Dec;10(5):293-303. Hungarian.

13.

Olanzapine plasma concentration, average daily dose, and interaction with co-medication in schizophrenic patients.

Bergemann N, Frick A, Parzer P, Kopitz J.

Pharmacopsychiatry. 2004 Mar;37(2):63-8.

PMID:
15048613
14.
15.

[Efficacy and tolerability of quetiapine in hospitalised schizophrenic patients during the acute treatment phase: a PMS study].

Leweke FM, Gerth CW, Koethe D, Nolden BM, Klosterkötter J.

Fortschr Neurol Psychiatr. 2007 Apr;75(4):211-9. Epub 2007 Jan 17. German.

PMID:
17230308
16.

The use of ziprasidone in clinical practice: analysis of pharmacokinetic and pharmacodynamic aspects from data of a drug monitoring survey.

Vogel F, Gansmüller R, Leiblein T, Dietmaier O, Wassmuth H, Gründer G, Hiemke C.

Eur Psychiatry. 2009 Apr;24(3):143-8. doi: 10.1016/j.eurpsy.2008.09.003. Epub 2008 Oct 23.

PMID:
18950992
17.

Therapeutic tolerance and rebound psychosis during quetiapine maintenance monotherapy in patients with schizophrenia and schizoaffective disorder.

Margolese HC, Chouinard G, Beauclair L, Bélanger MC.

J Clin Psychopharmacol. 2002 Aug;22(4):347-52.

PMID:
12172332
18.

The effect of multiple doses of cimetidine on the steady-state pharmacokinetics of quetiapine in men with selected psychotic disorders.

Strakowski SM, Keck PE Jr, Wong YW, Thyrum PT, Yeh C.

J Clin Psychopharmacol. 2002 Apr;22(2):201-5.

PMID:
11910267
19.

Quetiapine and clozapine in parkinsonian patients with dopaminergic psychosis.

Morgante L, Epifanio A, Spina E, Zappia M, Di Rosa AE, Marconi R, Basile G, Di Raimondo G, La Spina P, Quattrone A.

Clin Neuropharmacol. 2004 Jul-Aug;27(4):153-6. Erratum in: Clin Neuropharmacol. 2004 Sep-Oct;27(5):256.

PMID:
15319699
20.

A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.

DelBello MP, Chang K, Welge JA, Adler CM, Rana M, Howe M, Bryan H, Vogel D, Sampang S, Delgado SV, Sorter M, Strakowski SM.

Bipolar Disord. 2009 Aug;11(5):483-93. doi: 10.1111/j.1399-5618.2009.00728.x.

PMID:
19624387
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk